DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Online

2017 年 05 月 09 日 12:00 下午 - 2017 年 05 月 11 日 2:00 下午

Oversight of Clinical Monitoring: Trends and Strategies

Part 2:The Details of Site Monitoring

Session Chair(s)

Lynn  King, MHA

Lynn King, MHA

Consultant

United States

Part 2:
The Details of Site Monitoring

•Define ICH and FDA requirements for site monitoring
•Regulatory requirements for transferring contractual obligations
•Identify Sponsor responsibilities for oversight
•Introduce “Quality Oversight” programs
•Approaches to monitoring – Centralized and On-Site
•Metrics Champion Consortium – RBM Survey
•Audit/inspection observations and findings regarding site monitoring

Questions/Answers

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。